Abstract
One of the most intriguing observations on the effects of drugs used for the treatment of psychotic disorders is the relationship between the therapeutic effects of these drugs and their ability to produce parkinsonian-like extrapyramidal syndrome in man. It has been pointed out (Friedhoff 1969) that all effective antipsychotic drugs have the potential for producing a parkinsonian-like reaction in man. Effective drugs of divergent chemical structure which are used for the treatment of psychoses such as the phenothiazines, butyrophenones, and the rauwolfia alkaloids all have this potential. Within a given class, drugs which do not readily produce extrapyramidal disturbance are also ineffective antipsychotic agents. Among the phenothiazines, e.g., phenergan is one such drug with a low extrapyramidal disturbing potential. But again this compound is not an effective antipsychotic agent. Although not all patients receiving antipsychotic drugs develop clinical manifestations of Parkinsonism, it has been shown (Alpert 1967) through the use of a sensitive device for measuring resting finger tremor, that patients receiving effective doses of these drugs all have subclinical manifestations of extrapyramidal disturbance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alpert, M. (1967): The parameters of physiological and pathological tremor. In: Proceedings of the Ist NIMH Workshop on Tardive Dyskinesia, St. Louis, Mo., Jan.
Antón-Tay, F. and Wurtman, R. J. (1968): Norepinephrine: Turnover in rat brain after gonadectomy. Science159, 1245.
Barraclough, C. A. and Sawyer, C. H. (1957): Blockage of the release of pituitary ovulating hormone in the rat by chlorpromazine and reserpine: possible mechanisms of action. Endocrinology61, 341 – 351.
Baruk, M., Launay, J. and Berges, J. (1956): Physiologie psychiatrique expérimentale de la chlorpromazine chez les animaux et ses applications thérapeutiques chez l’homme. Encéphale 45, 1258–1263.
Ben-David, M., Dikstein, S. and Sulman, F. G. (1965): Production of lactation by non-sedative phenothiazine derivatives. Proc. Soc. exp. Biol. (N. Y).118, 265 – 270.
Benson, G. K. (1960): Further studies on the effects of tranquilizing drugs on mammary involution in the rat. Proc. Soc. exp. Biol. (N. Y.)103, 132 – 137.
Brillhart, J. R. (1959): Tranquilizer interference in the Rana pipiens chorionic gonadotropin test. Obstet, and Gynec.14, 581 – 587.
Brady, J. (1959): Comparative psychopharmacology: Animal experimental studies on effect of drugs on behavior. In: Psychopharmacology, Problems of Evaluation. Ed. by J. O. Cole and R. Gerard. Nat. Acad. Sci., Nat. Res. Council, Wash. D.C. pp. 46 – 63. Carworth Farms, Inc. Personal Communication. New City, Rockland County, New York, 1961.
CoTui, F., Brinitzer, W., Orr, A. and Orr, E. (1960): The effect of chlorpromazine and reserpine on adreno-cortical function. Psychiat. Quart.34, 47 – 61.
Courvoisier, S., Fournel, J., Ducrot, R., Kolsky, M. and Koetschet, P. (1953): Propriétés pharmacodynamiques du chlorhydrate de chloro-3-(dimethylamine-3′-propyl)10 phenothiazine. Arch. int. Pharmacodyn.92, 305 – 361.
Courvoisier, S., Ducrot, R. and Julou, L. (1957): New experimental aspects of the central activity of the phenothiazine derivatives. In: Psychotropic Drugs. Ed. by S. Garattini and V. Ghetti. E. L. Seevier, Princeton, N.J. pp. 373 – 391.
Dasgupta, S. R. and Hausler, H. F. (1955): The effect of chlorpromazine on the induced continuous estrus of ovariectomized rats. Bull. Calcutta Sch. trop. Med.3, 113–114.
Duvoisin, R. (1970): Behavioral abnormalities occurring in Parkinsonism during treatment with levodopa. In: 9th Annual Meeting of American College of Neuro-psychopharmacology, San Juan.
Essig, G. F. and Carter, W. W. (1957): Convulsions and bizarre behavior in monkeys receiving chlorpromazine. Proc. Soc. exp. Biol. (N. Y.)95, 726.
Fink, G. B. and Swinyard, E. A. (1960): Effect of psychopharmacologic agents on experimentally induced seizures in mice. J. Amer. pharm. Ass.49, 510–513.
Fotherby, K., Forrest, A. D. and Laverty, S. G. (1959): The effect of chlorpromazine on adrenocortical function. Acta endocr. (Kbh.)32, 425 – 436.
Freyhan, F. A. (1957): Psychomotility and Parkinsonism in treatment with neuroleptic drugs. Arch. Neurol. Psychiat. (Chic.)78, 465–472.
Freyhan, F. A. (1959): Selection of patients from the clinical point of view. In: Psychopharmacology. Problems of Evaluation. Ed. by J. O. Cole and R. W. Gerard. Nat. Acad. Sci., Nat, Res. Council, Wash. D.C. pp. 372 – 389.
Friedhoff, A. J. (1969): Methylation processes in schizophrenia. In: Schizophrenia, Current Concepts and Research. Ed. by D. V. Siva Sankar. PJD Publications. Hicks-ville, N.Y. pp. 552 – 556.
Friedhoff, A. J. and Alpert, M. (1960): The effect of chlorpromazine on the variability of motor task performances in schizophrenia. J. nerv. ment. Dis.130, 110 – 116.
Fuxe, K. and Hökfelt, T. (1966): Further evidence for the existence of tubero-infundibular dopamine neurons. Acta physiol. scand.66, 245 – 246.
Fuxe, K., Hökfelt, T. and Nilsson, O.(1967): Activity changes in the tubero-infundibular neurons of the rat during various states of the reproductive cycle. Life Sci.6, 2057–2061.
Gailitis, J., Knowles, R. and Longobard, A. (1960): Alarming neuromuscular reactions due to prochlorperazine. Ann. intern. Med.52, 538–543.
Gold, E. M., DiRaimondo, V. C., Kent, J. R. and Forsham, P. H. (1960): Comparative effects of certain non-narcotic central nervous system analgesics and muscle relaxants on pituitary adrenocortical system. In: Non-Narcotic Drugs for the Relief of Pain and their Mechanisms of Action. Ann. N.Y. Acad. Sci.86, 178 – 190.
Haase, H. J. (1959): The role of drug induced extrapyramidal syndromes. In: Psycho-pharmacology Frontiers. Ed. by N. S. Kline. Little, Brown and Co., New York. pp. 197–208.
Heilizer, F. (1959): The effects of chlorpromazine upon psychomotor and psychiatric behavior of chronic schizophrenic patients. J. nerv. ment. Dis.128, 358 – 364.
Heilizer, F. (1960): A critical review of some published experiments with chlorpromazine in schizophrenic, neurotic and normal humans. J. chron. Dis.11, 102 – 148.
Hornykiewicz, O. (1966): Dopamine (3-hydroxytryptamine) and brain function. Pharmacol. Rev.18, 925 – 964.
Irwin, S. and Govier, W. M. (1957): Chlorpromazine, a new tranquilizer: comparison with chlorpromazine in the mouse, rat. cat, dog and monkey. J. Pharmacol. exp. Ther.119, 154–155 (Abstract).
Khan, M. Y. and Bernstorf, E. C. (1964): Effect of chlorpromazine and reserpine upon pituitary function. Exp. Med. Surg.22, 363 – 378.
Khazen, K., Mishkinsky, J., Ben-David, M. and Sulman, F. G. (1968): Structure-activity relationship of mammotropic phenothiazine derivatives. Arch. int. Phar-macodyn.171, 251–273.
Kulcsár, S., Polishuk, W. and Rubin, L. (1957): Aspects endocriniens du traitement à la chlorpromazine. Presse méd.65, 1288 – 1290.
Lichtensteiger, W. (1969): Cyclic variations of catecholamine content in hypothalamic nerve cells during the estrous cycle of the rat, with a concomitant study of the substantia nigra. J. Pharmacol. exp. Ther.165, 204 – 215.
Lichtensteiger, W., Korpela, K., Langemann, H. and Keller, P. J. (1969): The influence of ovariectomy, estrogen and progesterone on the catecholamine content of hypothalamic nerve cells in the rat. Brain Res.16, 199 – 214.
May, R. H. and Voegel, G. E. (1956): Parkinsonism reactions following chlorpromazine and reserpine. Arch. Neurol. Psychiat. (Chic.)75, 522 – 524.
Paulson, G. (1959): Phenothiazine toxicity, extrapyramidal seizures and oculogyric crises. J. ment. Sci.105, 798 – 802.
Rahill, M. A. (1957): Mammarv gland changes during chlorpromazine therapy. Brit. med. J.2, 906.
Schneider, H. P. G. and McCann, S. M. (1969): Possible role of dopamine as transmitter to promote discharge of LH-releasing factor. Endocrinology85, 121 – 132.
Shelesnyak, M. C. (1954): Comparative effectiveness of antihistamines in suppression of the decidual cell reaction in the pseudopregnant rat. Endocrinology54, 396–401.
Siegel, S. (1956): In: Nonparametric Statistics for the Behavioral Sciences. Ed. by C. T. Morgan. McGraw-Hill Book Co., New York, N.Y. pp. 256–270.
Stefano, F. J. E. and Donoso, A. O. (1967): Norepinephrine levels in the rat hypothalamus during the estrous cycle. Endocrinology81, 1405 – 1406.
Suzuki, M., Kamio, K., Yasuda, M., Akiyama, S., Mitani, K., Oyama, T., Sato, K. and Yamashita, T. (1956): The effect of chlorpromazine on the function of the endocrine organs. Endocrin. jap.3, 67 – 72.
Taeschler, M. and Cerletti, A. (1959): Effets de quelques derives de la phenothiazine sur des réactions matrices et émotionnelles du rat. J. Physiol. (Paris)51, 873–878.
Talwalker, P. K. (1960): Initiation and maintenance of milk secretion in the rat following chlorpromazine administration. Fed. Proc.19, 157.
Tedeschi, D. H., Tedeschi, R. E., Cook, L., Mattis, P. and Fellows, E. J. (1959): The neuropharmacology of triflooperazine : a potent psychotherapeutic agent. Arch. int. Pharmacodyn.122, 129 – 143.
Velardo, J. T. (Ed.) (1958): In: The Endocrinology of Reproduction. Oxford University Press, New York. pp. 340.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Akadémiai Kiadó, Budapest, Hungary
About this chapter
Cite this chapter
Mislow, J.F., Friedhoff, A.J. (1973). A Comparison of Chlorpromazine-Induced Extrapyramidal Syndrome in Male and Female Rats. In: Lissák, K. (eds) Hormones and Brain Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2007-4_34
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2007-4_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2009-8
Online ISBN: 978-1-4684-2007-4
eBook Packages: Springer Book Archive